Pharma

Your Article Summary

See Latest Articles

Teva announces agreement on allegra patent challenge
Teva Pharmaceutical Industries, 11/20/08

Teva Pharmaceutical Industries Ltd. announced that its subsidiary, Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc. have signed an agreement with Aventis Pharmaceuticals, Inc., sanofi-aventis U.S. LLC and Albany Molecular Research, Inc. to settle patent litigation involving Teva's and Barr's U.S. generic versions of Aventis Pharmaceuticals' Allegra (fexofenadine) 30mg, 60mg and 180mg tablets including all claims for patent infringement and damages. After entering into a separate agreement with Barr, Teva launched its generic fexofenadine tablets in the U.S. in September 2005.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

New graduate degree offered focusing on health care quality
National Committee for Quality Assurance (NCQA), 06/11/09

GSK Signs Deal with Concert Pharma to the Tune of $1 Billion
PharmExec, 06/04/09

Sanofi-aventis and Kyowa Hakko Kirin enter into a Collaboration and Licensing Agreement on an Anti LIGHT fully human monoclonal antibody
Sanofi-aventis, 05/15/09

See All of M&A/Partnerships